We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes.AuthorsKong AP; Yamasaki A; Ozaki R; Saito H; Asami T; Ohwada S; Ko GT; Wong CK; Leung GT; Lee KF; Yeung CY; Chan JCPublicationDiabetes, obesity & metabolism, 2011, Vol 13, Issue 9, p806ISSN1463-1326Publication typearticleDOI10.1111/j.1463-1326.2011.01411.x